DE69837348D1 - Verfahren zur inaktivierung von bakterien mit einbegriff von bakteriensporen - Google Patents
Verfahren zur inaktivierung von bakterien mit einbegriff von bakteriensporenInfo
- Publication number
- DE69837348D1 DE69837348D1 DE69837348T DE69837348T DE69837348D1 DE 69837348 D1 DE69837348 D1 DE 69837348D1 DE 69837348 T DE69837348 T DE 69837348T DE 69837348 T DE69837348 T DE 69837348T DE 69837348 D1 DE69837348 D1 DE 69837348D1
- Authority
- DE
- Germany
- Prior art keywords
- bacteria
- inactivating
- spores
- oil
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000894006 Bacteria Species 0.000 title abstract 4
- 230000000415 inactivating effect Effects 0.000 title abstract 2
- 239000007764 o/w emulsion Substances 0.000 abstract 2
- 241000193830 Bacillus <bacterium> Species 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 210000004666 bacterial spore Anatomy 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/12—Iodine, e.g. iodophors; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Inorganic Chemistry (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/002,228 US6015832A (en) | 1997-12-31 | 1997-12-31 | Methods of inactivating bacteria including bacterial spores |
US2228 | 1997-12-31 | ||
PCT/US1998/027755 WO1999033459A1 (en) | 1997-12-31 | 1998-12-28 | Methods of inactivating bacteria including bacterial spores |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69837348D1 true DE69837348D1 (de) | 2007-04-26 |
DE69837348T2 DE69837348T2 (de) | 2007-11-29 |
Family
ID=21699801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69837348T Expired - Lifetime DE69837348T2 (de) | 1997-12-31 | 1998-12-28 | Verfahren zur inaktivierung von bakterien mit einbegriff von bakteriensporen |
Country Status (10)
Country | Link |
---|---|
US (1) | US6015832A (de) |
EP (1) | EP1041978B1 (de) |
JP (1) | JP4683724B2 (de) |
AT (1) | ATE356549T1 (de) |
AU (1) | AU749817B2 (de) |
CA (1) | CA2316888C (de) |
DE (1) | DE69837348T2 (de) |
HK (1) | HK1031839A1 (de) |
IL (1) | IL137093A (de) |
WO (1) | WO1999033459A1 (de) |
Families Citing this family (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6524592B2 (en) * | 1997-10-17 | 2003-02-25 | American Home Products Corporation | Veterinary vaccines |
US7390432B2 (en) * | 1998-06-30 | 2008-06-24 | Sandia Corporation | Enhanced formulations for neutralization of chemical, biological and industrial toxants |
US6723890B2 (en) | 1998-06-30 | 2004-04-20 | Sandia Corporation | Concentrated formulations and methods for neutralizing chemical and biological toxants |
US6506803B1 (en) * | 1999-04-28 | 2003-01-14 | Regents Of The University Of Michigan | Methods of preventing and treating microbial infections |
US6559189B2 (en) | 1999-04-28 | 2003-05-06 | Regents Of The University Of Michigan | Non-toxic antimicrobial compositions and methods of use |
US7655252B2 (en) | 1999-04-28 | 2010-02-02 | The Regents Of The University Of Michigan | Antimicrobial nanoemulsion compositions and methods |
US6635676B2 (en) * | 1999-04-28 | 2003-10-21 | Regents Of The University Of Michigan | Non-toxic antimicrobial compositions and methods of use |
US7767216B2 (en) * | 1999-04-28 | 2010-08-03 | The Regents Of The University Of Michigan | Antimicrobial compositions and methods of use |
US20030059839A1 (en) * | 2001-05-22 | 2003-03-27 | Obiso Richard J. | Method for detecting pathogens using immunoassays |
AU2002367976B2 (en) * | 2001-06-05 | 2007-06-21 | The Regents Of The University Of Michigan | Nanoemulsion vaccines |
JP2010209109A (ja) * | 2001-06-25 | 2010-09-24 | Regents Of The Univ Of Michigan | 抗微生物ナノエマルジョンの組成物および方法 |
MXPA04003603A (es) * | 2001-10-19 | 2005-04-11 | Innovative Constr & Build Mat | Medios de filtracion de aire antipatogenos y dispositivos para manejar aire que tienen capacidades protectoras contra microorganismos infecciosos transportados por el aire. |
EP1446009A2 (de) * | 2001-11-08 | 2004-08-18 | Merck & Co., Inc. | Verbindungen zur behandlung von anthrax |
US20040087564A1 (en) * | 2002-10-31 | 2004-05-06 | Wright D. Craig | Delivery composition and method |
US20050208083A1 (en) | 2003-06-04 | 2005-09-22 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof |
US8211448B2 (en) * | 2003-07-07 | 2012-07-03 | Nares Ab | Microemulsions and its use for preventing airway diseases |
ES2297442T3 (es) * | 2003-07-07 | 2008-05-01 | Nares Ab | Microemulsiones y su uso para prevenir enfermedades de las vias respiratorias. |
US20050100601A1 (en) * | 2003-11-07 | 2005-05-12 | Viratox, L.L.C. | Virucidal activities of cetylpyridinium chloride |
EP1851271A1 (de) * | 2005-01-11 | 2007-11-07 | Clean Earth Technologies, LLC | Persäure/peroxid-zusammensetzung und verwendung davon als antimikrobielles mittel und photosensibilisator |
WO2006110699A1 (en) * | 2005-04-11 | 2006-10-19 | Nanobio Corporation | Quaternary ammonium halides for treatment of infectious conditions |
WO2008051186A2 (en) | 2005-08-09 | 2008-05-02 | Nanobio Corporation | Nanoemulsion containing compositions having ant i -inflammatory activity |
US7797337B2 (en) * | 2005-09-29 | 2010-09-14 | Scenera Technologies, Llc | Methods, systems, and computer program products for automatically associating data with a resource as metadata based on a characteristic of the resource |
US10138279B2 (en) | 2006-04-13 | 2018-11-27 | Regents Of The University Of Michigan | Compositions and methods for Bacillus anthracis vaccination |
US9839685B2 (en) * | 2006-04-13 | 2017-12-12 | The Regents Of The University Of Michigan | Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen |
US20080038295A1 (en) * | 2006-04-13 | 2008-02-14 | Regents Of The University Of Michigan | Compositions and methods for orthopox virus vaccination |
CA2649457A1 (en) * | 2006-04-13 | 2007-10-25 | The Regents Of The University Of Michigan | Nanoemulsion vaccines |
US8741954B2 (en) * | 2007-02-21 | 2014-06-03 | Viratox, L.L.C. | Synergistic enhancement of calcium propionate |
US8747872B2 (en) * | 2007-05-02 | 2014-06-10 | The Regents Of The University Of Michigan | Nanoemulsion therapeutic compositions and methods of using the same |
JP2011518184A (ja) * | 2008-04-18 | 2011-06-23 | ナノバイオ コーポレーション | ヘルペスウイルス感染の治療方法 |
EP3023107A1 (de) | 2008-04-21 | 2016-05-25 | Nanobio Corporation | Nanoemulsions-influenza-impfstoff |
WO2009132343A1 (en) * | 2008-04-25 | 2009-10-29 | Nanobio Corporation | Nanoemulsions for treating onchomycosis |
JP2011518844A (ja) * | 2008-04-25 | 2011-06-30 | ナノバイオ コーポレーション | 真菌、酵母および糸状菌感染症を治療するためのナノエマルション |
AU2009293595A1 (en) * | 2008-05-23 | 2010-03-25 | The Regents Of The University Of Michigan | Nanoemulsion adjuvants |
US8877208B2 (en) | 2008-05-23 | 2014-11-04 | The Regents Of The University Of Michigan | Multivalent nanoemulsion vaccines |
EP2349209A2 (de) | 2008-09-26 | 2011-08-03 | Nanobio Corporation | Therapeutische zusammensetzungen in nanoemulsionsform und anwendungsverfahren dafür |
WO2010042212A2 (en) | 2008-10-10 | 2010-04-15 | Dara Biosciences, Inc. | Methods for treating or preventing pain using spicamycin derivatives |
WO2010045367A1 (en) * | 2008-10-14 | 2010-04-22 | Dr Pepper/Seven Up, Inc. | Shelf-stable consumable compositions containing probiotic-mimicking elements and methods of preparing and using the same |
CA2743904A1 (en) | 2008-11-17 | 2010-05-20 | The Regents Of The University Of Michigan | Cancer vaccine compositions and methods of using the same |
US20100226983A1 (en) * | 2009-01-28 | 2010-09-09 | Nanobio Corporation | Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof |
US8668911B2 (en) | 2009-05-14 | 2014-03-11 | The Regents Of The University Of Michigan | Streptococcus vaccine compositions and methods of using the same |
JP5771605B2 (ja) | 2009-05-22 | 2015-09-02 | ジェノセア バイオサイエンシーズ, インコーポレイテッド | 単純ヘルペスウイルス2型に対するワクチン:免疫応答を誘発する組成物および方法 |
EP3020412B1 (de) | 2009-06-16 | 2017-10-11 | The Regents of the University of Michigan | Nanoemulsionsimpfstoffe |
US20110229512A1 (en) * | 2010-03-19 | 2011-09-22 | The Regents Of The University Of Michigan | Compositions and methods for diagnosing and treating urinary tract infections |
JP2014520805A (ja) | 2011-07-06 | 2014-08-25 | ナノバイオ コーポレーション | ヒト呼吸器合胞体ウイルスワクチン |
EP3329936A1 (de) | 2011-08-22 | 2018-06-06 | Nanobio Corporation | Impfstoff gegen den herpes-simplex-virus als nanoemulsion |
US9561271B2 (en) | 2011-09-09 | 2017-02-07 | Nanobio Corporation | Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine |
EP2782597B1 (de) | 2011-11-23 | 2022-04-13 | Genocea Biosciences, Inc. | Nukleinsäureimpfstoffe gegen den herpes-simplex-virus vom typ 2: zusammensetzungen und verfahren zur auslösung einer immunreaktion |
EP4112076A1 (de) | 2014-10-10 | 2023-01-04 | The Regents of The University of Michigan | Nanoemulsionszusammensetzungen zur prävention, unterdrückung oder eliminierung von allergischen und entzündlichen erkrankungen |
ES2905181T3 (es) | 2015-05-01 | 2022-04-07 | Prec Biosciences Inc | Deleción precisa de secuencias cromosómicas in vivo |
US11173197B2 (en) | 2015-07-07 | 2021-11-16 | Bluewillow Biologics, Inc. | Methods and compositions for nanoemulsion vaccine formulations |
CA2997909A1 (en) | 2015-09-08 | 2017-03-16 | Precision Biosciences, Inc. | Treatment of retinitis pigmentosa using engineered meganucleases |
DK3359660T3 (en) | 2015-10-05 | 2020-02-17 | Prec Biosciences Inc | Engineered meganucleases with recognition sequences found in the human t cell receptor alpha constant region gene |
EP3756682B8 (de) | 2015-10-05 | 2022-04-27 | Precision Biosciences, Inc. | Genetisch veränderte zellen mit gen aus konstanter alpha-region modifizierter menschlicher t-zell-rezeptoren |
CA3009637A1 (en) | 2015-12-23 | 2017-06-29 | Precision Biosciences, Inc. | Engineered meganucleases with recognition sequences found in the human beta-2 microglobulin gene |
NZ745936A (en) | 2016-04-27 | 2020-02-28 | Univ Puerto Rico | 1,5-disubstituted 1,2,3-triazoles are inhibitors of rac/cdc42 gtpases |
ES2905791T3 (es) | 2016-05-03 | 2022-04-12 | Prec Biosciences Inc | Nucleasas de ingeniería útiles para el tratamiento de la hemofilia A |
WO2017201390A1 (en) | 2016-05-19 | 2017-11-23 | The Regents Of The University Of Michigan | Novel adjuvant compositions |
EP3519427A4 (de) | 2016-09-28 | 2020-03-11 | Genocea Biosciences Inc. | Verfahren und zusammensetzungen zur behandlung von herpes |
EP3757120B8 (de) | 2016-10-04 | 2022-06-15 | Precision Biosciences, Inc. | Co-stimulierende domänen zur verwendung bei genetisch veränderten zellen |
KR102305215B1 (ko) | 2016-10-14 | 2021-09-28 | 프리시젼 바이오사이언시스 인코포레이티드 | B형 간염 바이러스 게놈 내의 인식 서열에 대해 특이적인 조작된 메가뉴클레아제 |
WO2018073393A2 (en) | 2016-10-19 | 2018-04-26 | Cellectis | Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy |
CN110769845B (zh) | 2017-04-21 | 2023-08-15 | 精密生物科学公司 | 对pcsk9基因中的识别序列具有特异性的工程化大范围核酸酶 |
WO2018201144A1 (en) | 2017-04-28 | 2018-11-01 | Precision Biosciences, Inc. | Methods for reducing dna-induced cytotoxicity and enhancing gene editing in primary cells |
CA3062698A1 (en) | 2017-05-08 | 2018-11-15 | Precision Biosciences, Inc. | Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof |
WO2019005957A1 (en) | 2017-06-30 | 2019-01-03 | Precision Biosciences, Inc. | GENETICALLY MODIFIED T CELLS COMPRISING A MODIFIED INTRON IN THE ALPHA T CELL RECEPTOR GENE |
CA3074212A1 (en) * | 2017-08-28 | 2019-03-07 | University Of Louisiana At Lafayette | Method of manufacture for hand-sanitizing lotion with prolonged effectiveness and resulting composition of matter |
WO2019070856A1 (en) | 2017-10-03 | 2019-04-11 | Precision Biosciences, Inc. | MODIFIED EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDES FOR USE IN GENETICALLY MODIFIED CELLS |
US20200299658A1 (en) | 2017-11-01 | 2020-09-24 | Precision Biosciences, Inc. | Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a |
US11142750B2 (en) | 2018-04-12 | 2021-10-12 | Precision Biosciences, Inc. | Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome |
AU2019252527B2 (en) | 2018-04-12 | 2024-02-22 | Precision Biosciences, Inc. | Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene |
US20210393554A1 (en) | 2018-11-15 | 2021-12-23 | Bluewillow Biologics, Inc. | Nanoemulsion compositions having enhanced permeability |
US11369578B2 (en) | 2018-11-15 | 2022-06-28 | Bluewillow Biologics, Inc. | Persistent topical antimicrobial compositions and methods of using the same |
EP3898661A1 (de) | 2018-12-21 | 2021-10-27 | Precision BioSciences, Inc. | Genetische modifikation des hydroxysäure-oxidase-1-gens zur behandlung von primärer hyperoxalurie |
CA3135799A1 (en) | 2019-04-03 | 2020-10-08 | Precision Biosciences, Inc. | Genetically-modified immune cells comprising a microrna-adapted shrna (shrnamir) |
US20220273715A1 (en) | 2019-07-25 | 2022-09-01 | Precision Biosciences, Inc. | Compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus |
AU2020333851A1 (en) | 2019-08-20 | 2022-03-31 | Precision Biosciences, Inc. | Lymphodepletion dosing regimens for cellular immunotherapies |
WO2021087305A1 (en) | 2019-10-30 | 2021-05-06 | Precision Biosciences, Inc. | Cd20 chimeric antigen receptors and methods of use for immunotherapy |
WO2021113543A1 (en) | 2019-12-06 | 2021-06-10 | Precision Biosciences, Inc. | Methods for cancer immunotherapy, using lymphodepletion regimens and cd19, cd20 or bcma allogeneic car t cells |
WO2021113765A1 (en) | 2019-12-06 | 2021-06-10 | Precision Biosciences, Inc. | Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome |
WO2021231259A1 (en) | 2020-05-11 | 2021-11-18 | Precision Biosciences, Inc. | Self-limiting viral vectors encoding nucleases |
EP4150068A1 (de) | 2020-05-12 | 2023-03-22 | Precision BioSciences, Inc. | Behandlung von retinitis pigmentosa mit verbesserten manipulierten meganukleasen |
EP4192875A1 (de) | 2020-08-10 | 2023-06-14 | Precision BioSciences, Inc. | Antikörper und fragmente spezifisch für b-zellreifungsantigen und verwendungen davon |
WO2022035309A1 (en) * | 2020-08-14 | 2022-02-17 | Universiti Putra Malaysia | Nano emulsion composition having antimicrobial properties |
AU2021329403A1 (en) | 2020-08-21 | 2023-05-04 | Precision Biosciences, Inc. | Engineered meganucleases having specificity for a recognition sequence in the transthyretin gene |
KR20230118841A (ko) | 2020-11-12 | 2023-08-14 | 프리시젼 바이오사이언시스 인코포레이티드 | 디스트로핀 유전자 내의 인식 서열에 대해 특이성을 갖는 조작된 메가뉴클레아제 |
WO2022150616A1 (en) | 2021-01-08 | 2022-07-14 | Precision Biosciences, Inc. | Engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 gene |
EP4284823A1 (de) | 2021-01-28 | 2023-12-06 | Precision BioSciences, Inc. | Modulation der tgf-beta-signalisierung in genetisch modifizierten eukaryotischen zellen |
EP4326862A1 (de) | 2021-04-22 | 2024-02-28 | Precision Biosciences, Inc. | Manipulierte meganukleasen gegen menschliche mitochondriale genome |
EP4326861A1 (de) | 2021-04-22 | 2024-02-28 | Precision Biosciences, Inc. | Manipulierte meganukleasen gegen menschliche mitochondriale genome |
AU2022368911A1 (en) | 2021-10-19 | 2024-05-30 | Precision Biosciences, Inc. | Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency |
AU2022371430A1 (en) | 2021-10-19 | 2024-05-30 | Precision Biosciences, Inc. | Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency |
WO2023081767A1 (en) | 2021-11-05 | 2023-05-11 | Precision Biosciences, Inc. | Methods for immunotherapy |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4020183A (en) * | 1974-12-03 | 1977-04-26 | Ortho Pharmaceutical Corporation | Nonionic surface active anti-herpes simplex viral agents |
US4412985A (en) * | 1980-10-06 | 1983-11-01 | Edward Shanbrom | Depyrogenation process |
US4540573A (en) * | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
US4909940A (en) * | 1987-12-30 | 1990-03-20 | New York Blood Center, Inc. | Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons |
JPH089525B2 (ja) * | 1988-06-22 | 1996-01-31 | アプライド マイクロバイオロジー,インコーポレイテッド | 強化広域殺菌剤として使用されるナイシン組成物 |
US5156973A (en) * | 1988-11-23 | 1992-10-20 | Edward Shanbrom | Antiviral blood sampling process and apparatus |
JP3628343B2 (ja) * | 1993-11-01 | 2005-03-09 | 亘起物産有限会社 | ウィルス不活化剤 |
JPH07196408A (ja) * | 1993-12-28 | 1995-08-01 | Amano Pharmaceut Co Ltd | 抗菌性組成物 |
US5547677A (en) * | 1994-05-20 | 1996-08-20 | Novavax, Inc. | Antimicrobial oil-in-water emulsions |
US5549901A (en) * | 1994-05-20 | 1996-08-27 | Novavax, Inc. | Antimicrobial oil-in-water emulsions |
EP0760650B1 (de) * | 1994-05-20 | 2002-07-31 | Novavax, Inc. | Antimikrobielle öl-in-wasser-emulsionen |
US6034073A (en) * | 1995-04-24 | 2000-03-07 | Novavax, Inc. | Solvent detergent emulsions having antiviral activity |
JP2868206B2 (ja) * | 1996-04-16 | 1999-03-10 | 株式会社オフテクス | 消毒および/または防腐のための有害微生物防除用組成物 |
-
1997
- 1997-12-31 US US09/002,228 patent/US6015832A/en not_active Expired - Lifetime
-
1998
- 1998-12-28 DE DE69837348T patent/DE69837348T2/de not_active Expired - Lifetime
- 1998-12-28 IL IL137093A patent/IL137093A/en not_active IP Right Cessation
- 1998-12-28 WO PCT/US1998/027755 patent/WO1999033459A1/en active IP Right Grant
- 1998-12-28 EP EP98964997A patent/EP1041978B1/de not_active Expired - Lifetime
- 1998-12-28 CA CA002316888A patent/CA2316888C/en not_active Expired - Lifetime
- 1998-12-28 JP JP2000526216A patent/JP4683724B2/ja not_active Expired - Lifetime
- 1998-12-28 AT AT98964997T patent/ATE356549T1/de not_active IP Right Cessation
- 1998-12-28 AU AU20198/99A patent/AU749817B2/en not_active Expired
-
2001
- 2001-04-11 HK HK01102591A patent/HK1031839A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69837348T2 (de) | 2007-11-29 |
IL137093A0 (en) | 2001-06-14 |
IL137093A (en) | 2007-03-08 |
US6015832A (en) | 2000-01-18 |
AU749817B2 (en) | 2002-07-04 |
JP2001527041A (ja) | 2001-12-25 |
AU2019899A (en) | 1999-07-19 |
EP1041978A4 (de) | 2004-05-19 |
HK1031839A1 (en) | 2001-06-29 |
EP1041978A1 (de) | 2000-10-11 |
WO1999033459A1 (en) | 1999-07-08 |
ATE356549T1 (de) | 2007-04-15 |
CA2316888C (en) | 2007-06-19 |
EP1041978B1 (de) | 2007-03-14 |
JP4683724B2 (ja) | 2011-05-18 |
CA2316888A1 (en) | 1999-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69837348D1 (de) | Verfahren zur inaktivierung von bakterien mit einbegriff von bakteriensporen | |
DE69432351D1 (de) | Verfahren zum sterilisieren von produkten | |
DE3280150D1 (de) | Mikroorganismen fuer den mikrobiellen abbau von schaedlichen organischen abfallstoffen in unschaedliche materialien. | |
DE59403670D1 (de) | Verfahren zur unterkritischen trocknung von aerogelen | |
BG101748A (en) | Heterocyclic condensated pyridines | |
DE69506882T2 (de) | Wasserlösliche organische salze von kreatin | |
DE69910790D1 (de) | Bakterien als mittel für teppiche zur unterdrückung von schlechten gerüchen | |
ATE201906T1 (de) | Zusammenwetzungen und verfahren zur entgiftung von zearalenon | |
SE9404250D0 (sv) | Affinity separation method | |
FR2744125B1 (fr) | Copolymeres greffes, leur procede de fabrication, les compositions les contenant et leur utilisation pour la preparation de dispersions pigmentaires en milieu aqueux et/ou organique | |
ATE149367T1 (de) | Chemisch-biologisches verfahren zur dehalogenierung von halogenierten organischen verbindungen | |
DE69811709D1 (de) | Bekämpfungsmittel gegen pflanzenpathogene mikro-organismen | |
EA200000196A1 (ru) | Универсальная плазма крови | |
ATE165116T1 (de) | Nachweis von mikrobiellem wachstum | |
DE69917061D1 (de) | Nitrocumarine für den nachweis aller mikroorganismen | |
DE69719497D1 (de) | Verfahren zur proteinaufreinigung aus einer proteinhaltigen lösung | |
ATE242336T1 (de) | Verfahren zur vebesserung des wachstums und des kolorimetrischen nachweises von bakterien, hefen, pilzen oder kokken | |
ATE229479T1 (de) | Verfahren zur kontrolle von mikrobenverschmutzung in wässrigen feststoffsuspensionen | |
DE59000468D1 (de) | Verfahren zur schnellen pruefung der wirksamkeit von agenzien auf mikroorganismen. | |
ATE213782T1 (de) | Verfahren zur biotransformation von colchicinoid- verbindungen in die entsprechenden 3- glycosylderivate | |
MX9407876A (es) | Formulaciones de hongos entomopatogenos para uso como insecticidas biologicos. | |
DE60236996D1 (de) | Kulturmedium zum nachweis von bakterien der gattung listeria | |
DE69728911D1 (de) | Verfahren zur bekämpfung von mikroorganismen | |
KR950700988A (ko) | 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof) | |
DE3778158D1 (de) | Inhibitoren von esterase produzierenden mikroorganismen zur hauptverwendung in deodorants. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |